Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a prospective, multi‐center, randomized controlled phase II clinical trial aimedat exploring the efficacy evaluation of cadilonilumab immunotherapy combined withchemotherapy for locally advanced cervical cancer.
Epistemonikos ID: c30c7077e75da5da6b7642a4ba2401c58bbd3a9f
First added on: Jun 17, 2026